Concepedia

Rishi Sekar

RS

5

Publications

85

Citations

5

H-Index

2017

Active since

Affiliations

University of Michigan(Current)

Emory University

Fred Hutch Cancer Center

University of Washington

Rishi Sekar is an author at University of Michigan specializing in surgical oncology, cancer therapeutics, and molecular oncology.

ORCID

Top concepts

Publications per year

2017–2024

5

Publications

5

Evaluation of programmed cell death protein 1 (PD-1) expression as a prognostic biomarker in patients with clear cell renal cell carcinoma

Kyu Seo Kim, Rishi Sekar, Dattatraya Patil et al. · OncoImmunology · 2017 · 30 citations · Full text

Response to Neoadjuvant Chemotherapy and Survival in Micropapillary Urothelial Carcinoma: Data From a Tertiary Referral Center and the Surveillance, Epidemiology, and End Results (SEER) Program

Leonidas Nikolaos Diamantopoulos, Sarah K. Holt, Ali Raza Khaki et al. · Clinical Genitourinary Cancer · 2020 · 19 citations · Full text

, , +12

A novel preoperative inflammatory marker prognostic score in patients with localized and metastatic renal cell carcinoma

Rishi Sekar, Dattatraya Patil, Yoram Baum et al. · Asian journal of urology · 2017 · 14 citations · Full text

Social Determinants of Health and the Availability of Cancer Clinical Trials in the United States

Rishi Sekar, Lindsey A. Herrel, Kristian Stensland · JAMA Network Open · 2024 · 12 citations · Full text

Sarcomatoid Urothelial Carcinoma Is Associated With Limited Response to Neoadjuvant Chemotherapy and Poor Oncologic Outcomes After Radical Cystectomy

Rishi Sekar, Leonidas Nikolaos Diamantopoulos, Dimitra Rafailia Bakaloudi et al. · Clinical Genitourinary Cancer · 2023 · 10 citations · Full text

Rows per page

1–5 of 5